Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_assertion type Assertion NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_head.
- NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_assertion wasGeneratedBy ECO_0000203 NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_provenance.
- NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_assertion wasDerivedFrom befree-20140225 NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_provenance.
- NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_assertion SIO_000772 17996038 NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_provenance.
- NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_assertion evidence source_evidence_literature NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_provenance.
- NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_assertion description "[The gene-gene interaction analyses demonstrated that individuals with combined GSTT1 null and NAT2 slow acetylators had an additional increased risk of gastric cancer, with an OR of 3.00 (95%CI: 1.52-5.93) and an AP of 52%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388764.RAmyPTkIUaLMU-cxBdXoRP3yDMILl6L-qGjsbAtO45Ock130_provenance.